loadpatents
Patent applications and USPTO patent grants for Bender; John A..The latest application filed is for "4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication".
Patent | Date |
---|---|
Inhibitors of human immunodeficiency virus replication Grant 10,954,252 - Babu , et al. March 23, 2 | 2021-03-23 |
4-oxo-3,4-dihydroquinazoline Compounds As Inhibitors Of Human Immunodeficiency Virus Replication App 20210024503 - BELEMA; Makonen ;   et al. | 2021-01-28 |
Inhibitors of human immunodeficiency virus replication Grant 10,221,129 - Bender , et al. | 2019-03-05 |
Inhibitors of human immunodeficiency virus replication Grant 10,035,760 - Pendri , et al. July 31, 2 | 2018-07-31 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20180086697 - BENDER; John A. ;   et al. | 2018-03-29 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20180072997 - BENDER; John A. ;   et al. | 2018-03-15 |
Inhibitors of human immunodeficiency virus replication Grant 9,855,230 - Belema , et al. January 2, 2 | 2018-01-02 |
Hepatitis C Virus Inhibitor App 20170355689 - LAVOIE; RICO ;   et al. | 2017-12-14 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20170304239 - BELEMA; Makonen ;   et al. | 2017-10-26 |
Hepatitis C virus inhibitors Grant 9,776,981 - Lavoie , et al. October 3, 2 | 2017-10-03 |
2-keto amide derivatives as HIV attachment inhibitors Grant 9,586,957 - Wang , et al. March 7, 2 | 2017-03-07 |
Hepatitis C virus inhibitors Grant 9,561,212 - Romine , et al. February 7, 2 | 2017-02-07 |
Hepatitis C virus inhibitors Grant 9,546,160 - Chen , et al. January 17, 2 | 2017-01-17 |
Hepatitis C Virus Inhibitors App 20160338999 - Romine; Jeffrey Lee ;   et al. | 2016-11-24 |
4,4'-biphenyldiyl-bis-(1 H-imidazolyl) Derivatives As Hepatitis Hcv Inhibitors App 20160311806 - Bender; John A. ;   et al. | 2016-10-27 |
Inhibitors Of Human Immunodeficiency Virus Replication App 20160257645 - Pendri; Annapurna ;   et al. | 2016-09-08 |
Hepatitis C virus inhibitors Grant 9,340,520 - Lopez , et al. May 17, 2 | 2016-05-17 |
2-keto Amide Derivatives As Hiv Attachment Inhibitors App 20160052924 - Wang; Tao ;   et al. | 2016-02-25 |
Hepatitis C Virus Inhibitors App 20150322048 - Lavoie; Rico ;   et al. | 2015-11-12 |
Hepatitis C Virus Inhibitors App 20150252028 - Romine; Jeffrey Lee ;   et al. | 2015-09-10 |
Hepatitis C Virus Inhibitors App 20150197499 - Lavoie; Rico ;   et al. | 2015-07-16 |
Hepatitis C virus inhibitors Grant 8,809,548 - Romine , et al. August 19, 2 | 2014-08-19 |
Hepatitis C virus inhibitors Grant 8,796,466 - Bender , et al. August 5, 2 | 2014-08-05 |
Hepatitis C Virus Inhibitors App 20140205564 - Romine; Jeffrey Lee ;   et al. | 2014-07-24 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20140186299 - Bender; John A. ;   et al. | 2014-07-03 |
Compounds for the treatment of hepatitis C Grant 8,722,688 - Yeung , et al. May 13, 2 | 2014-05-13 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20140045816 - Bender; John A. ;   et al. | 2014-02-13 |
Hepatitis C Virus Inhibitors App 20140018389 - Lavoie; Rico ;   et al. | 2014-01-16 |
Hepatitis C Virus Inhibitors App 20140012020 - Lopez; Omar D. ;   et al. | 2014-01-09 |
Hepatitis C virus inhibitors Grant 8,618,153 - Bender , et al. December 31, 2 | 2013-12-31 |
Hepatitis C virus inhibitors Grant 08618153 - | 2013-12-31 |
Hepatitis C virus inhibitors Grant 8,552,047 - Bender , et al. October 8, 2 | 2013-10-08 |
Compounds for the treatment of hepatitis C Grant 8,536,338 - Pracitto , et al. September 17, 2 | 2013-09-17 |
Compounds for the Treatment of Hepatitis C App 20130197012 - Yeung; Kap-Sun ;   et al. | 2013-08-01 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20130171098 - Bender; John A. ;   et al. | 2013-07-04 |
Hepatitis C Virus Inhibitors App 20130121957 - Chen; Qi ;   et al. | 2013-05-16 |
Hepatitis C Virus Inhibitors App 20130115193 - Lavoie; Rico ;   et al. | 2013-05-09 |
Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors Grant 8,431,568 - Bender , et al. April 30, 2 | 2013-04-30 |
Hepatitis C virus inhibitors Grant 8,377,980 - Belema , et al. February 19, 2 | 2013-02-19 |
Hepatitis C Virus Inhibitors App 20130028859 - Bender; John A. ;   et al. | 2013-01-31 |
Hepatitis C Virus Inhibitors App 20130012540 - Lavoie; Rico ;   et al. | 2013-01-10 |
Compounds for the Treatment of Hepatitis C App 20120316126 - Yeung; Kap-Sun ;   et al. | 2012-12-13 |
Compounds for the treatment of hepatitis C Grant 8,309,558 - Yeung , et al. November 13, 2 | 2012-11-13 |
Compounds for the treatment of hepatitis C Grant 8,293,909 - Pracitto , et al. October 23, 2 | 2012-10-23 |
Compounds for the Treatment of Hepatitis C App 20120232099 - Pracitto; Richard ;   et al. | 2012-09-13 |
Compounds For The Treatment Of Hepatitis C App 20120201783 - Yeung; Kap-Sun ;   et al. | 2012-08-09 |
Hepatitis C Virus Inhibitors App 20120195857 - Belema; Makonen ;   et al. | 2012-08-02 |
Compounds for the treatment of hepatitis C Grant 8,198,449 - Pracitto , et al. June 12, 2 | 2012-06-12 |
Compounds for the Treatment of Hepatitis C App 20120115847 - Hewawasam; Piyasena ;   et al. | 2012-05-10 |
Compounds for the treatment of hepatitis C Grant 8,148,382 - Yeung , et al. April 3, 2 | 2012-04-03 |
Hepatitis C virus inhibitors Grant 8,143,414 - Lavoie , et al. March 27, 2 | 2012-03-27 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 8,143,244 - Bender , et al. March 27, 2 | 2012-03-27 |
Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors Grant 8,138,171 - Bender , et al. March 20, 2 | 2012-03-20 |
Compounds for the treatment of Hepatitis C Grant 8,129,367 - Hewawasam , et al. March 6, 2 | 2012-03-06 |
Compounds for the treatment of Hepatitis C Grant 8,124,601 - Bender , et al. February 28, 2 | 2012-02-28 |
Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors Grant 8,119,628 - Yang , et al. February 21, 2 | 2012-02-21 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20110311480 - Bender; John A. ;   et al. | 2011-12-22 |
Hepatitis C Virus Inhibitors App 20110286961 - Belema; Makonen ;   et al. | 2011-11-24 |
Hepatitis C Virus Inhibitors App 20110281910 - Lavoie; Rico ;   et al. | 2011-11-17 |
Hepatitis C Virus Inhibitors App 20110274648 - Lavoie; Rico ;   et al. | 2011-11-10 |
Compounds for the treatment of hepatitis C Grant 8,048,887 - Yeung , et al. November 1, 2 | 2011-11-01 |
Compounds for the Treatment of Hepatitis C App 20110256099 - Yeung; Kap-Sun ;   et al. | 2011-10-20 |
Compounds for the treatment of hepatitis C Grant 7,994,171 - Yeung , et al. August 9, 2 | 2011-08-09 |
Hepatitis C Virus Inhibitors App 20110098327 - Lavoie; Rico ;   et al. | 2011-04-28 |
Hepatitis C Virus Inhibitors App 20110077280 - Bender; John A. ;   et al. | 2011-03-31 |
Diazaindole-dicarbonyl-piperazinyl antiviral agents Grant 7,902,204 - Bender , et al. March 8, 2 | 2011-03-08 |
Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhibitors App 20110020277 - Bender; John A. ;   et al. | 2011-01-27 |
Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors App 20110020276 - Yang; Zhong ;   et al. | 2011-01-27 |
Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors App 20110014154 - Bender; John A. ;   et al. | 2011-01-20 |
Compounds for the Treatment of Hepatitis C App 20100249094 - Yeung; Kap-Sun ;   et al. | 2010-09-30 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20100216774 - Bender; John A. ;   et al. | 2010-08-26 |
Hepatitis C Virus Inhibitors App 20100215616 - Romine; Jeffrey Lee ;   et al. | 2010-08-26 |
Compounds for the Treatment of Hepatitis C App 20100184800 - Pracitto; Richard ;   et al. | 2010-07-22 |
Compounds for the Treatment of Hepatitis C App 20100093694 - Yeung; Kap-Sun ;   et al. | 2010-04-15 |
Compounds for the Treatment of Hepatitis C App 20100063068 - Pracitto; Richard ;   et al. | 2010-03-11 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20090162318 - Bender; John A. ;   et al. | 2009-06-25 |
Compounds for the treatment of Hepatitis C Grant 7,547,690 - Gentles , et al. June 16, 2 | 2009-06-16 |
Compounds for the treatment of hepatitis C Grant 7,541,351 - Bender , et al. June 2, 2 | 2009-06-02 |
Compounds for the treatment of hepatitis C Grant 7,541,353 - Gentles , et al. June 2, 2 | 2009-06-02 |
Compounds for the treatment of Hepatitis C Grant 7,538,102 - Yeung , et al. May 26, 2 | 2009-05-26 |
Compounds for the Treatment of Hepatitis C App 20090130057 - Hewawasam; Piyasena ;   et al. | 2009-05-21 |
Compounds for the Treatment of Hepatitis C App 20090130056 - Bender; John A. ;   et al. | 2009-05-21 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,521,441 - Gentles , et al. April 21, 2 | 2009-04-21 |
Compounds for the treatment of hepatitis C Grant 7,521,444 - Bender , et al. April 21, 2 | 2009-04-21 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,521,443 - Bender , et al. April 21, 2 | 2009-04-21 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,485,633 - Meanwell , et al. February 3, 2 | 2009-02-03 |
Indolobenzazepine HCV NS5B inhibitors Grant 7,473,688 - Bergstrom , et al. January 6, 2 | 2009-01-06 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,456,166 - Bender , et al. November 25, 2 | 2008-11-25 |
Compounds for the Treatment of Hepatitis C App 20080227769 - Gentles; Robert G. ;   et al. | 2008-09-18 |
Compounds for the Treatment of Hepatitis C App 20080226592 - Yeung; Kap-Sun ;   et al. | 2008-09-18 |
Compounds for the Treatment of Hepatitis C App 20080226591 - Gentles; Robert G. ;   et al. | 2008-09-18 |
Compounds for the Treatment of Hepatitis C App 20080226590 - Bender; John A. ;   et al. | 2008-09-18 |
Compounds for the Treatment of Hepatitis C App 20080171015 - Bender; John A. ;   et al. | 2008-07-17 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,399,758 - Meanwell , et al. July 15, 2 | 2008-07-15 |
Cyclopropyl Fused Indolobenzazepine Hcv Ns5b Inhibitors App 20080146537 - Bender; John A. ;   et al. | 2008-06-19 |
Diazaindole-dicarbonyl-piperazinyl Antiviral Agents App 20080125439 - Bender; John A. ;   et al. | 2008-05-29 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070270406 - Gentles; Robert G. ;   et al. | 2007-11-22 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070270405 - Bender; John A. ;   et al. | 2007-11-22 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070184024 - Meanwell; Nicholas A. ;   et al. | 2007-08-09 |
Indolobenzazepine HCV NS5B inhibitors App 20070078122 - Bergstrom; Carl P. ;   et al. | 2007-04-05 |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors App 20070060565 - Meanwell; Nicholas A. ;   et al. | 2007-03-15 |
Diazaindole-dicarbonyl-piperazinyl antiviral agents App 20050124623 - Bender, John A. ;   et al. | 2005-06-09 |
Antiviral azaindole derivatives Grant 6,900,323 - Wang , et al. May 31, 2 | 2005-05-31 |
Indole, azaindole and related heterocyclic amidopiperazine derivatives Grant 6,825,201 - Wang , et al. November 30, 2 | 2004-11-30 |
Antiviral azaindole derivatives App 20040023982 - Wang, Tao ;   et al. | 2004-02-05 |
Antiviral azaindole derivatives Grant 6,632,819 - Wang , et al. October 14, 2 | 2003-10-14 |
Antiviral azaindole derivatives App 20030181463 - Wang, Tao ;   et al. | 2003-09-25 |
Indole, azaindole and related heterocyclic amidopiperazine derivatives App 20030096825 - Wang, Tao ;   et al. | 2003-05-22 |
Antiviral azaindole derivatives Grant 6,476,034 - Wang , et al. November 5, 2 | 2002-11-05 |
Antiviral azaindole derivatives App 20020119982 - Wang, Tao ;   et al. | 2002-08-29 |
Antiviral azaindole derivatives App 20020061892 - Wang, Tao ;   et al. | 2002-05-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.